Myovant Sciences Ltd (N:MYOV)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MYOV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 7/20 Apr 6/20 Sumitomo Chemical Co., Ltd. Indirect Ownership Common Stock P - Open market or private purchase 70,000 $8.44
Apr 7/20 Apr 3/20 Seely Lynn Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 302,693  
Apr 7/20 Apr 3/20 Seely Lynn Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 197,659  
Apr 7/20 Apr 3/20 Sablich Kim Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 134,464  
Apr 7/20 Apr 3/20 Sablich Kim Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 87,805  
Apr 7/20 Apr 3/20 Lang Matthew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 170,396  
Apr 7/20 Apr 3/20 Lang Matthew Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 111,268  
Apr 7/20 Apr 3/20 Karbe Frank Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 183,991  
Apr 7/20 Apr 3/20 Karbe Frank Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 120,146  
Apr 7/20 Apr 3/20 Arjona Ferreira Juan Camilo Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 134,464  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MYOV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 7/20 Apr 3/20 Seely Lynn Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 302,693  
Apr 7/20 Apr 3/20 Seely Lynn Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 197,659  
Apr 7/20 Apr 3/20 Sablich Kim Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 134,464  
Apr 7/20 Apr 3/20 Sablich Kim Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 87,805  
Apr 7/20 Apr 3/20 Lang Matthew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 170,396  
Apr 7/20 Apr 3/20 Lang Matthew Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 111,268  
Apr 7/20 Apr 3/20 Karbe Frank Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 183,991  
Apr 7/20 Apr 3/20 Karbe Frank Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 120,146  
Apr 7/20 Apr 3/20 Arjona Ferreira Juan Camilo Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 134,464  
Apr 7/20 Apr 3/20 Arjona Ferreira Juan Camilo Direct Ownership Common Shares A - Grant, award or other under Rule 16b-3(d) 87,805  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MYOV

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)